Implementing policy change to advance equity in kidney care requires interdisciplinary support and institutional readiness, ...

Data presented at Kidney Week 2025 showed single subcutaneous administration of megalin-STRIKERs resulted in increased excretion of disease-related solute levels lasting for at least 2 months Dr. Ravi ...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: ...

Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the “Best of JAMA and NEJM” session - RADNOR, Pa., ...

XPHOZAH is the first and only phosphate absorption inhibitor (PAI) approved by the U.S. Food and Drug Administration to reduce serum phosphorus in adults with chronic kidney disease on dialysis as add ...

Nephrologists must capitalize on new therapeutic agents and opportunities to carry on the momentum of the field, according to ...

Advancing Sight Network and Miracles In Sight today jointly announced the merger of the two organizations, which will begin operating as one on January 1, 2026. This press release features multimedia.

When millions of people suddenly couldn't load familiar websites and apps during the Amazon Web Services, or AWS, outage on Oct. 20, 2025, the affected servers weren't actually down. The problem was ...

Because of the government shutdown, many families will not have SNAP benefits, leaving many wondering how they'll feed their ...

Broadcast Retirement Network's Jeffrey Snyder discusses how lifestyle and diet can lower your dementia risk with Tuft ...